Navigation Links
Dow AgroSciences, Agrisoma Biosciences Announce Research and Commercial License Option Agreement for Agricultural Crops
Date:12/1/2009

INDIANAPOLIS and NORTH VANCOUVER, British Columbia, Dec. 1 /PRNewswire-FirstCall/ -- Dow AgroSciences LLC, a wholly owned subsidiary of The Dow Chemical Company (NYSE: DOW), and Agrisoma Biosciences, Inc. today announced the signing of a research and commercial license option agreement. The agreement provides Dow AgroSciences with access to Agrisoma's proprietary Engineered Trait Loci (ETL) technology on an exclusive basis in major food crops, and on a non-exclusive basis, in other crop species.

Dow AgroSciences and Agrisoma have collaborated since 2004 in the area of high value protein production in plants and plant cell cultures. The initial collaboration formed the foundation of a successful relationship. This new agreement builds on that relationship and expands use of the ETL technology into field crops.

"Dow AgroSciences' strategic investment in Agrisoma's ETL technology will accelerate the creation of new and novel products in crop plants, such as increased levels and improved forms of healthier oils or other beneficial food components," said Dan Kittle, Ph.D., Dow AgroSciences vice president for R&D. "ETL technology will be an important tool in our 'toolbox' to deliver differentiated solutions enabled by the expression of multiple genes or enhancements in complex biochemical pathways."

Agrisoma's ETL technology is a patent protected, broadly applicable technology that facilitates the placement of new traits in the native genome of a crop. The ETL technology has been used to engineer oil composition, oil content and yield for the renewable energy market and ETL-engineered crops are now undergoing a second year of field trials at multiple locations.

"We recognize Dow AgroSciences as a premiere global leader in plant biotechnology and are tremendously excited about the opportunity to expand our collaboration with Dow AgroSciences," said Steven Fabijanski, Agrisoma's president and chief executive officer. "Agrisoma has demonstrated the utility, stability and performance our ETL technology in a broad range of crops, including important food crops such as soybeans and canola. Our ETL technology has proven performance, and through this new collaboration with Dow AgroSciences, we hope to be able to commercialize this technology in major global food crops. The research collaboration with Dow AgroSciences complements our industrial crop program which is focused on creating renewable feedstocks using dedicated bioenergy plants."

About Agrisoma Biosciences

Agrisoma Biosciences Inc. is a private agricultural biotechnology company using its leading edge ETL technology to create new crop varieties engineered for high value applications such as biofuel production and renewable manufacturing feedstock. Agrisoma's ETL, or Engineered Trait Loci technology allows efficient stacking and expression of multiple traits in any crop species. For further information about Agrisoma, and its technology, collaborations and partnerships, please visit: www.agrisoma.com

About Dow AgroSciences LLC

Dow AgroSciences LLC, based in Indianapolis, Indiana, USA, is a top-tier agricultural company that combines the power of science and technology with the "Human Element" to constantly improve what is essential to human progress. Dow AgroSciences provides innovative technologies for crop protection, pest and vegetation management, seeds, traits, and agricultural biotechnology to serve the world's growing population. Global sales for Dow AgroSciences, a wholly owned subsidiary of The Dow Chemical Company (NYSE: DOW), are $4.5 billion. Learn more at www.dowagro.com.

Note: Certain of the statements contained in this press release are forward-looking statements which involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements.

SOURCE Dow AgroSciences


'/>"/>
SOURCE Dow AgroSciences
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Dow AgroSciences, Monsanto Complete U.S. and Canadian Regulatory Authorizations for SmartStax Corn; Plans Set to Launch Seed Platform on 3 Million- to 4 Million-Plus Acres
2. Dow AgroSciences, NemGenix Establish New Collaboration in Plant Biotechnology
3. Dow AgroSciences, China National Rice Research Institute Announce Collaboration on Rice Research
4. Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestones in Plant Agriculture Collaboration
5. Dow AgroSciences, Martek Biosciences Form Alliance to Bring Omega-3 Fatty Acids to Food Industry
6. Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestone in Plant Agriculture Collaboration
7. Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference
8. YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA
9. American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor
10. Sangamo BioSciences Provides Update on Phase 1 Safety Trial of SB-728-T for HIV/AIDS
11. YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB RESULTS IN ADVANCED TRIPLE-NEGATIVE BREAST CANCER MODEL PRESENTED AT AACR-NCI-EORTC MEETING
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... , Feb. 16, 2017  MDNA Life Sciences ... development of liquid biopsy tests based on the ... an exclusive license agreement with its first international ... liquid biopsy test for prostate cancer, the Prostate ... . This is the first overseas appointment ...
(Date:2/16/2017)... DUBLIN , Feb. 16, 2017 ... the "Synthetic Biology: Global Markets" report to ... ... synthetic-biology products (synthetic genes, biobrick parts, delivery plasmids, chassis ... DNA synthesis and assembly, genome editing, bioinformatics and specialty ...
(Date:2/16/2017)... Feb. 16, 2017   Biostage, Inc. (Nasdaq: ... biotechnology company developing bioengineered organ implants to treat cancers ... trachea, announced today the closing on February 15, 2017 ... of common stock and warrants to purchase 20,000,000 shares ... million. The offering was priced at $0.40 per share ...
(Date:2/16/2017)... DENVER , Feb. 16, 2017 UCHealth ... hospital to utilize LungDirect for pulmonary nodule patient management. ... a nodule, or a spot on the lung, UCHealth ... spent on manual data entry. Stephanie ... been tracking my nodule patients with an Excel spreadsheet, ...
Breaking Biology Technology:
(Date:2/3/2017)... -- Texas Biomedical Research Institute announced that its Board of Trustees ... the Institute,s new President and CEO. Dr. Schlesinger will take ... is currently the Chair of the Department of Microbial Infection ... Biology at Ohio State University. "We are delighted ... of Texas Biomed," said Dr. James O. Rubin , ...
(Date:2/2/2017)... , Feb. 1, 2017  Central to ... and meaningful advances worldwide, The Japan Prize Foundation ... Prize, who have pushed the envelope in their ... and Communication. Three scientists are being recognized with ... achievements that not only contribute to the advancement ...
(Date:1/26/2017)... Jan. 26, 2017  Crossmatch, a leading provider of ... solution aimed at combatting fraud, waste and abuse in ... at the Action on Disaster Relief conference in ... for UN agencies and foreign assistance organizations throughout ... and abuse are a largely unacknowledged problem in the ...
Breaking Biology News(10 mins):